CMSC: Consortium of Multiple Sclerosis Centers
Video
VIDEO: PML prevention is possible, even when treating patients with aggressive MS
NASHVILLE, TENN. – Short treatment periods with natalizumab are possible for patients with aggressive disease, even with JC virus antibody...
Video
Research on exercise in MS needs to build up some muscle
Researchers hope to increase the number of studies on cognitive rehabilitation and exercise in MS, just as has happened recently to rehab in...
Video
Pediatric MS gets a win with fingolimod
NASHVILLE, TENN. – First successful phase 3 study in pediatric MS may lead to a reshaping of the pediatric MS treatment paradigm.
Video
Inside the complex, surprising world of MS comorbidities
Research suggests some conditions are more common in MS. Cancer is an outlier: Its rates may actually be lower than in the general population.
Video
Value-based care spawns new challenges for MS physicians
NASHVILLE, TENN. – Quality measures for MS aren’t designed to address patient needs, an advocate says, and cost issues spell more trouble.
Video
iPad app puts cognitive screening in the hands of MS patients
The Multiple Sclerosis Performance Test app attempts to sidestep the problem of time and manpower in administering cognitive screening.
Conference Coverage
CMSC looks to increase advocacy efforts to address looming concerns
Two educational sessions on advocacy aim to inform attendees about specific resources and stakeholders involved in challenges to the MS community...
Conference Coverage
Rehabilitation in MS is hot topic at CMSC 2018
High-quality research into the most effective practices, however, is still sparse.
Conference Coverage
Wide variety of MS topics on tap at CMSC 2018
Annual meeting will tackle stem cells, ethics, new drugs, suicide, and more.
Conference Coverage
Integrative approach to MS care underused, expert says
NEW ORLEANS – “There is a very evidence-based approach to integrative medicine. The core of it still is not familiar to a lot of physicians,” said...
Conference Coverage
Preliminary results promising from ublituximab phase II study for MS
NEW ORLEANS – The investigative agent ublituximab was well tolerated and demonstrated rapid B-cell depletion in relapsing multiple sclerosis.
Conference Coverage
Can Exercise Boost Cognitive Performance in Patients With MS?
NEW ORLEANS—A single bout of treadmill walking might affect cognitive processing to a greater degree than stationary cycling, particularly among...
Conference Coverage
When Should Neurologists Discontinue Disease-Modifying Treatments in Patients With MS?
NEW ORLEANS—Discontinuation of disease modifying treatments (DMTs) may be considered for patients with secondary progressive multiple sclerosis (...
Conference Coverage
Pregnancy and MS: How do they affect each other?
NEW ORLEANS – Researchers understand how MS affects pregnancy, but less about how pregnancy factors impact MS disease activity.
Conference Coverage
Study sheds light on pregnancy outcomes following ocrelizumab treatment
The study shows pregnancy outcomes data for women with multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus.